Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Toshi Kajiro"'
Autor:
Ryunosuke Kitamura, Takefumi Kawabe, Yumiko Masuda, Toshi Kajiro, Koichi Nonaka, Etsuo Yonemochi
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 1193
The International Conference on Harmonization guidelines for quality on pharmaceutical development recommends a systematic development approach including robustness studies which assure performance of manufacturing and analytical method development o
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 198
The ICH guidance on pharmaceutical development recommends a systematic development approach including robustness studies which assure performance of manufacturing and analytical method development of drug product. The retention model by T. Kawabe et
Publikováno v:
Analytical Chemistry. 74:4519-4525
A microdialysis (MD) technique, combined with HPLC-fluorescence (FL) detection, was developed for the evaluation of the tissue-specific renin-angiotensin system (RAS) in the rat renal cortex. An MD probe constructed with a hydrophilic hollow fiber di
Publikováno v:
The Analyst. 125:1115-1121
Water-soluble fluorogenic reagents having a 2,1,3-benzoxadiazole (benzofurazan) structure, 2-(7-fluoro-2,1,3-benzoxadiazole-4-sulfonamido)ethanesulfonic acid (ES-ABD-F), 4-(7-fluoro-2,1,3-benzoxadiazole-4-sulfonamido)benzenesulfonic acid (p-BS-ABD-F)
Publikováno v:
Journal of chromatography. A. 1273
An optimization procedure of ternary isocratic mobile phase composition in the HPLC method using a statistical prediction model and visualization technique is described. In this report, two prediction models were first evaluated to obtain reliable pr
Autor:
Michiko Konno, Tomonori Murakami, Naoyuki Kishi, Yoko Kawaguchi-Murakami, Naoto Fukutsu, Toshi Kajiro, Tetsuya Araki, Takao Kawasaki
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 50(3)
Stress conditions for predicting oxidative degradation products in solid-state pharmaceutical compounds were investigated. 4-Methyl-2-(3,4-dimethylphenyl)-1-(4-sulfamoylphenyl)pyrrole, Compound A, was used as the model compound for this study and its
Publikováno v:
Analytical biochemistry. 297(1)
Bradykinin (BK) in rat urine was determined by coupled-column HPLC with precolumn fluorogenic derivatization with a water-soluble reagent, 3-(7-fluoro-2,1,3-benzoxadiazole-4-sulfonamido)benzenesulfonic acid ( m -BS-ABD-F). The derivatization of BK wi
Publikováno v:
Photochemical & Photobiological Sciences; Apr2003, Vol. 2 Issue 4, p443-449, 7p